Facebook
X
LinkedIn
ForwardAdvances in Food Allergy Management for Pediatric Patients
1.25 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members.
Pediatric nurse practitioners often play a critical role in recognizing immunoglobulin (Ig)-E–mediated food allergies (FAs) and discussing appropriate therapeutic options with patients and their caregivers. Recent treatment advances have introduced novel options that are reshaping the FA management paradigm, requiring pediatric providers to learn how best to incorporate these treatments into evidence-based management plans. In this interactive, discussion-based CE activity, experts in the field discuss the burden of FA and its treatment on patients and caregivers, outline guideline-recommended approaches for identifying severe FA in pediatric patients, report the latest clinical data on newly approved FA therapies for managing pediatric patients with FA, and detail effective interprofessional and multispecialty strategies to improve coordination of care for patients with severe FA.
Educational Partner
Support Statement
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the CE posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, NAPNAP will issue a NAPNAP CE Contact Hours Certificate.
Accessibility
Vindico Medical Education is committed to providing an inclusive learning environment and ensuring equitable access to our educational content. Our educational activities may include accessibility features, such as captioning, transcripts, reading aloud, and other platform-supported tools, to assist learners.
Participants who require additional accommodation, alternative formats, or assistance accessing content are encouraged to contact us at [email protected]. Vindico will make all reasonable efforts to provide alternative formats in a timely manner.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2026 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher.
The material presented at or in any National Association of Pediatric Nurse Practitioners and Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of National Association of Pediatric Nurse Practitioners or Vindico Medical Education. Neither National Association of Pediatric Nurse Practitioners nor Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:
• Specify the copyrighted work you believe has been infringed upon.
• Describe the work and, if possible, include the location (e.g., URL) of an authorized version of the work.
• Share your name, address, telephone number, and, if available, your email address.
• Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
• Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
• Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
[email protected]
or call: 856-994-9400, ext. 614
CE Questions?
Contact us at [email protected]
Contact us at [email protected]
Target Audience
The intended audience for this activity includes pediatric nurse practitioners who are involved in the management of patients with food allergies.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
• Recognize the burden of FA and its treatment as experienced by patients and caregivers.
• Use guideline-recommended approaches to identify pediatric patients with severe FA and refer to a specialist as warranted.
• Incorporate newly approved FA therapies in the current management of pediatric patients with FA.
• Use effective interprofessional and multispecialty strategies to improve care coordination for patients with severe FA.
Activity Chair
Ruchi S. Gupta, MD, MPH
Founding Director, Center for Food Allergy & Asthma Research (CFAAR)
Professor of Pediatrics and Medicine, Northwestern University Feinberg School of Medicine
Clinical Attending, Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, IL
Faculty:
Kelly Cleary, MD, FAAP
Medical Director/VP of Health and Education
Food Allergy Research & Education (FARE)
McLean, VA
Maria Crain, APRN, CPNP-PC
Pediatric Nurse Practitioner
Director of Food Challenge Unit
Food Allergy Center at Children's Health/
UT Southwestern Medical Center
Dallas, TX
Anna H. Nowak-Wegrzyn, MD, PhD, AAAAI, EAACI, ACAAI
Professor of Pediatrics
NYU Grossman School of Medicine
Hassenfeld Children's Hospital
New York, NY
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Linda A. Giarraputo, BS, PA-C
Barbara A. Niedz, PhD, RN, CPHQ
Disclosures
The National Association of Pediatric Nurse Practitioners and Vindico Medical Education adhere to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s):
Ruchi S. Gupta, MD, MPH
Consultant: ARS Pharmaceuticals, Bryn Pharma, DBV Technologies, Genentech, Kaléo, OWYN
Kelly Cleary, MD, FAAP
No relevant financial relationships to disclose
Maria Crain, APRN, CPNP-PC
No relevant financial relationships to disclose
Anna H. Nowak-Wegrzyn, MD, PhD, AAAAI, EAACI, ACAAI
Advisor: DBV Technologies, Genentech, Nestlé
Consultant: Danone, Nestlé
Independent Research Contractor: ALK, DBV Technologies, Siolta Therapeutics
Planners/Reviewers report the following relevant financial relationship(s):
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose
Linda A. Giarraputo, BS, PA-C
No relevant financial relationships to disclose
Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose
National Association of Pediatric Nurse Practitioners and Vindico Medical Education Staff
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Accreditation and Credit Designation
In support of improving patient care, this activity has been planned and implemented by the National Association of Pediatric Nurse Practitioners and Vindico Medical Education.
This program is accredited by the National Association of Pediatric Nurse Practitioners (NAPNAP) for 1.25 NAPNAP CE contact hour, of which 0.25 is pharmacology (Rx) content.
This enduring material is approved for 1 year from the date of original release, June 1, 2026, to May 31, 2027.
Available Credit
- 1.25 Contact hours